Chinese ABRAXANE® supply expected to be disrupted
The marketing agent for China, BeiGene, announced the China National Medical Products Administration (NMPA) suspended the importation, sales and use of ABRAXANE.
List view / Grid view
The marketing agent for China, BeiGene, announced the China National Medical Products Administration (NMPA) suspended the importation, sales and use of ABRAXANE.
According to a recent article, China has approved a number of home-grown vaccines, offering alternatives to global drugmakers' products.
Following positive clinical trials, the Tagrisso drug has been given marketing authorisation in China for treatment of NSCLC.